MAGENTA THERAPEUTICS, INC.

(MGTA)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 17-08-2022
1.700 USD   +4.29%
17/08Magenta Therapeutics kondigt de benoeming aan van Michael Vasconcelles tot lid van de Raad van Bestuur, het Comité voor Onderzoek en Ontwikkeling en het Comité voor Benoemingen en Corporate Governance
CI
04/08Magenta Therapeutics, Inc. Rapporteert Winstresultaten voor het Tweede Kwartaal en de Zes Maanden Eindigend op 30 Juni, 2022
CI
24/05MAGENTA THERAPEUTICS, INC. : Goldman Sachs handhaaft koopadvies
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op MAGENTA THERAPEUTICS, INC.
17/08MAGENTA THERAPEUTICS : Appoints Michael Vasconcelles, M.D. to the Board of Directors - For..
17/08MAGENTA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Regulation FD Disc..
17/08Magenta Therapeutics Appoints Michael Vasconcelles, M.D. to the Board of Directors
17/08Magenta Therapeutics Announces Appointment of Michael Vasconcelles to its Board of Dire..
04/08MAGENTA THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
04/08Magenta Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Mont..
04/08MAGENTA THERAPEUTICS : Reports Second Quarter Financial Results and Recent Program Highlig..
04/08Magenta Therapeutics Reports Second Quarter Financial Results and Recent Program Highli..
02/08Magenta Therapeutics to Participate in Panel Discussion at the 2022 Wedbush PacGrow Hea..
30/06MAGENTA THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K..
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell Small Cap Comp Growth Ind..
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 2000 Growth Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 2000 Dynamic Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 2000 Defensive Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 2000 Growth-Defensive Ind..
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 2000 Value-Defensive Inde..
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 2000 Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 2000 Value Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 2500 Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 3000E Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 3000 Growth Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 3000E Value Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 2500 Growth Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 3000 Value Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell Microcap Growth Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell Small Cap Comp Value Inde..
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 2500 Value Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell Small Cap Completeness In..
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 3000 Index
24/06MAGENTA THERAPEUTICS, INC.(NASDAQGM : MGTA) dropped from Russell 3000E Growth Index
16/05MAGENTA THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
16/05Magenta Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 3..
16/05Magenta Therapeutics Reports First Quarter Financial Results, Early Clinical Observatio..
12/05NORTH AMERICAN MORNING BRIEFING : Stocks Seen -3-
02/05MAGENTA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statemen..
30/04MAGENTA THERAPEUTICS : April Corporate Presentation
18/04Magenta Therapeutics Shares Drop After Slew of Target Cuts
14/04SECTOR UPDATE : Health Care Stocks Fading Late, Stop Just Shy of Higher Close
14/04SECTOR UPDATE : Health Care Stocks Edging Lower on Thursday
14/04Magenta Therapeutics to Focus Capital Spending on Leukemia Drug Trial, Cut Workforce by..
14/04MAGENTA THERAPEUTICS : Focuses R&D and Operational Spending, Reduces Workforce and Extends..
14/04MAGENTA THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (..
14/04Magenta Therapeutics Focuses R&D and Operational Spending, Reduces Workforce and Extend..
14/04Magenta Therapeutics Focuses R&D and Operational Spending, Reduces Workforce and Extend..
08/03MAGENTA THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
08/03MAGENTA THERAPEUTICS : Reports Fourth Quarter and Full-Year 2021 Financial Results and Rec..
08/03Magenta Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31..
08/03Magenta Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended Decemb..
08/03Magenta Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Re..
03/03Magenta Therapeutics to Participate in Panel Discussion at the 42nd Annual Cowen Health..
02/03NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
13/01TRANSCRIPT : Magenta Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Confer..
10/01MAGENTA THERAPEUTICS : J.P. Morgan 2022 Presentation
10/01MAGENTA THERAPEUTICS : Highlights Recent Pipeline Progress and Milestone Expectations for ..
10/01Magenta Therapeutics Highlights Recent Pipeline Progress and Milestone Expectations for..
10/01Magenta Therapeutics Highlights Recent Pipeline Progress and Milestone Expectations for..
07/01NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
05/01Magenta Therapeutics to Present at the J.P. Morgan Healthcare Conference and the B. Ril..
2021Magenta Therapeutics Highlights Presentations of Data Related to Stem Cell Mobilization..
2021Magenta Therapeutics Highlights Presentations of Data Related to Stem Cell Mobilization..
2021Magenta Therapeutics Reports Third Quarter Financial Results and Program Highlights
2021Magenta Therapeutics Announces Data Presentations Related to its Mobilization and Condi..
2021MAGENTA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
2021Magenta Therapeutics Reports Third Quarter Financial Results and Program Highlights - F..
2021Magenta Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
2021MAGENTA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Other Events, ..
2021MAGENTA THERAPEUTICS : Appoints Jeffrey Humphrey, M.D. as Chief Medical Officer
2021Magenta Therapeutics Appoints Jeffrey Humphrey, M.D. as Chief Medical Officer
2021MAGENTA THERAPEUTICS : to Participate in 2021 Cantor Virtual Global Healthcare Conference
2021Top Premarket Decliners
2021MAGENTA THERAPEUTICS : Gets FDA Clearance for Leukemia Drug Trial, Plans Phase 1/2 Study i..
2021Magenta Therapeutics Gets IND Clearance for MGTA-117
2021MAGENTA THERAPEUTICS : Announces IND Clearance for MGTA-117 Targeted Conditioning Clinical..
2021Magenta Therapeutics, Inc. Announces That Its Investigational New Drug Application for ..
2021TSCAN THERAPEUTICS : Names Zoran Zdraveski as Chief Legal Officer
1  2  3  4  5Volgende
Volgende evenement op MAGENTA THERAPEUTICS, INC.